This paper analyses the case report of a 62-year-old man diagnosed with retroperitoneal tumour and severe intensity of neuropathic pain localized in the right lower extremity. Patient was administrated prolonged– release oxycodone/naloxone tablets as well as adjuvant analgesics. Previous pain treatment was inefficient due to inadequate dosage of prolonged–release oxycodone/naloxone tablets, lack of the use of adjuvant analgesics and unrecognition of depression. After introduction of changes in pharmacotherapy of pain and depression and psychological support satisfactory analgesic effect and significant mood improvement have been achieved
Opioid antagonists naloxone and naltrexone administered in ultra low doses are able to control pain ...
Compression of the obturator nerve can result in severe, opioid-resistant pain experienced by a pati...
Introduction: Opioids are the most commonly used medication in palliative cancer pain treatment due ...
This paper analyses the case report of a 62-year-old man diagnosed with retroperitoneal tumour and s...
Despite the wide availability of analgesics for prescription in cancer pain, including both opioid a...
Entrapment neuropathies are common in patients with advanced diseases including cancer. They may cau...
Introduction: The use of opioids is fundamental in moderate and severe pain management. There is ani...
Most of the problems in pain control in end of life care are encountered due to three main syndromes...
In moderate and strong cancer pain oxycodone has become one of the most effective and popular opioid...
Abstract: Chronic pain is one of the most important health problems from the XXI century due to its ...
Prolonged opioid treatment reveals problems, like opioid tolerance and opioid induced hyperalgesia. ...
Background: Neuropathic pain is the most common form of chronic pain often associated with impaired ...
Aim of the study: To compare analgesia and adverse effects during oral morphine and oxycodone and tr...
INTRODUCTION: Cancer-related pain has a severe negative impact on quality of life. Combination a...
Neuropathic pain (NP) is a chronic, debilitating symptomatology of lesions/injuries of the central a...
Opioid antagonists naloxone and naltrexone administered in ultra low doses are able to control pain ...
Compression of the obturator nerve can result in severe, opioid-resistant pain experienced by a pati...
Introduction: Opioids are the most commonly used medication in palliative cancer pain treatment due ...
This paper analyses the case report of a 62-year-old man diagnosed with retroperitoneal tumour and s...
Despite the wide availability of analgesics for prescription in cancer pain, including both opioid a...
Entrapment neuropathies are common in patients with advanced diseases including cancer. They may cau...
Introduction: The use of opioids is fundamental in moderate and severe pain management. There is ani...
Most of the problems in pain control in end of life care are encountered due to three main syndromes...
In moderate and strong cancer pain oxycodone has become one of the most effective and popular opioid...
Abstract: Chronic pain is one of the most important health problems from the XXI century due to its ...
Prolonged opioid treatment reveals problems, like opioid tolerance and opioid induced hyperalgesia. ...
Background: Neuropathic pain is the most common form of chronic pain often associated with impaired ...
Aim of the study: To compare analgesia and adverse effects during oral morphine and oxycodone and tr...
INTRODUCTION: Cancer-related pain has a severe negative impact on quality of life. Combination a...
Neuropathic pain (NP) is a chronic, debilitating symptomatology of lesions/injuries of the central a...
Opioid antagonists naloxone and naltrexone administered in ultra low doses are able to control pain ...
Compression of the obturator nerve can result in severe, opioid-resistant pain experienced by a pati...
Introduction: Opioids are the most commonly used medication in palliative cancer pain treatment due ...